GlaxoSmithKline logo

External affairs

We believe that GSK can make a valuable contribution to the debate on public policy issues that impact our business, in particular those relating to research and development, the use of pharmaceuticals and healthcare.

In most countries the pharmaceutical business is highly regulated. These regulations can have a significant impact on our ability to discover, develop and bring to patients innovative medicines. This makes it important for us to work closely with governments and regulatory authorities in a constructive way.

Our Government and External Affairs Departments monitor changes and proposed reforms to legislation and present our views on policy to governments. Our work is governed by our Code of Conduct, and backed up by factual research and analysis.

Our approach to working with governments is based on three principles:

  • Partnership: we are committed to working with governments and regulatory authorities in a constructive way.
  • Communication: as well as giving our views we take on board any concerns from external audiences on healthcare delivery. This enables GSK to assess and improve its business practices.
  • Integrity: GSK bases its case on research, analysis and facts. We respect other opinions and look for constructive solutions. All of our external affairs work must be in line with our Code of Conduct and other relevant policies including those related to Competition Law, Preventing Corrupt Practices, and Political Contributions.
* Back to top
Image of a world map
Research & development
Clinical Trial Register.

Visit the CTR website


Research and development
Research & development
Find out more

About R&D at GSK

This section contains information in several formats:

To download PDF files you will need Adobe Reader. If you do not have it installed, it is available free from the Adobe website. PDF links on this site open in a new window.

For audio-visual content you can use either Windows Media Player or Real Player, which can be installed free from their respective websites.